American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$493M |
| 2 |
Colgate-Palmolive
CL
|
+$367M |
| 3 |
Microsoft
MSFT
|
+$328M |
| 4 |
Fidelity National Information Services
FIS
|
+$298M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WP
Worldpay, Inc.
WP
|
+$300M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$268M |
| 3 |
Medtronic
MDT
|
+$233M |
| 4 |
Intercontinental Exchange
ICE
|
+$201M |
| 5 |
STI
SunTrust Banks, Inc.
STI
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.66% |
| 2 | Technology | 16% |
| 3 | Healthcare | 15% |
| 4 | Consumer Discretionary | 11.58% |
| 5 | Industrials | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Mid-America Apartment Communities
MAA
$15.4B
| $4.38M | ﹤0.01% |
+33,704
| New | +$4.19M |
|
827
Townsquare Media
TSQ
$103M
| $4.37M | ﹤0.01% |
622,139
+109,497
| +21% | +$663K |
|
828
Snap
SNAP
$8.79B
| $4.33M | ﹤0.01% |
273,788
+36,682
| +15% | +$587K |
|
829
iShares Core MSCI EAFE ETF
IEFA
$196B
| $4.3M | ﹤0.01% |
70,500
+37,100
| +111% | +$2.24M |
|
830
Materion
MTRN
$5.9B
| $4.28M | ﹤0.01% |
+69,820
| New | +$4.33M |
|
831
OFG Bancorp
OFG
$2.23B
| $4.28M | ﹤0.01% |
195,570
-15,918
| -8% | -$350K |
|
832
Rush Enterprises Class A
RUSHA
$9.41B
| $4.25M | ﹤0.01% |
247,892
+1,852
| +0.8% | +$30.8K |
|
833
Emergent Biosolutions
EBS
$233M
| $4.17M | ﹤0.01% |
+79,711
| New | +$3.71M |
|
834
Barrett Business Services
BBSI
$756M
| $4.16M | ﹤0.01% |
187,300
+32
| +0% | +$695 |
|
835
National Healthcare
NHC
$3.47B
| $4.16M | ﹤0.01% |
50,815
-15,911
| -24% | -$1.32M |
|
836
iShares MSCI Taiwan ETF
EWT
$11.4B
| $4.16M | ﹤0.01% |
114,345
+24,852
| +28% | +$876K |
|
|
VGR
837
DELISTED
Vector Group Ltd.
VGR
| $4.06M | ﹤0.01% |
481,003
-1
| -0% | -$8 |
|
|
AMRN
838
Amarin Corp
AMRN
$297M
| $4.06M | ﹤0.01% |
13,383
+7,059
| +112% | +$2.46M |
|
839
Vanguard S&P 500 ETF
VOO
$1.03T
| $4.03M | ﹤0.01% |
14,800
+4,700
| +47% | +$1.28M |
|
840
Myriad Genetics
MYGN
$309M
| $4.02M | ﹤0.01% |
140,369
-3,386
| -2% | -$98.7K |
|
841
Lumen
LUMN
$6.49B
| $4.02M | ﹤0.01% |
321,839
-148,005
| -32% | -$1.76M |
|
842
Maximus
MMS
$2.85B
| $4.01M | ﹤0.01% |
51,897
-601
| -1% | -$45.6K |
|
|
EPAY
843
DELISTED
Bottomline Technologies Inc
EPAY
| $4M | ﹤0.01% |
101,769
-17,733
| -15% | -$745K |
|
844
iShares Core S&P 500 ETF
IVV
$904B
| $3.94M | ﹤0.01% |
13,200
+4,100
| +45% | +$1.22M |
|
845
Patterson-UTI
PTEN
$4.2B
| $3.92M | ﹤0.01% |
458,582
+87,507
| +24% | +$858K |
|
846
Interparfums
IPAR
$3.78B
| $3.89M | ﹤0.01% |
+55,637
| New | +$3.69M |
|
847
SiriusPoint
SPNT
$2.66B
| $3.88M | ﹤0.01% |
+388,192
| New | +$3.89M |
|
848
Oneok
OKE
$58.3B
| $3.85M | ﹤0.01% |
52,295
+5,916
| +13% | +$419K |
|
|
POLY
849
DELISTED
Plantronics, Inc.
POLY
| $3.85M | ﹤0.01% |
103,262
-5,102
| -5% | -$174K |
|
|
PRNB
850
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $3.85M | ﹤0.01% |
136,472
+53,520
| +65% | +$1.96M |
|
Similar funds
American Century Companies's Q3 2019 Portfolio in Review
As of Q3 2019, American Century Companies held 1,407 positions worth $99.6B, down 0.83% from $100B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
American Century Companies's Q3 2019 filing shows 144 new, 546 increased, 497 reduced and 204 closed positions. Its largest new stake was A.O. Smith: 2,750,567 shares worth $131M. The largest sale was Worldpay, Inc., an estimated $300M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- American Century Companies's largest Q3 2019 buy was A.O. Smith: 2,750,567 shares worth $131M.
- American Century Companies added most to Pfizer in Q3 2019, an estimated $493M increase.
- American Century Companies's biggest Q3 2019 reduction was Medtronic, cutting an estimated $233M.
- American Century Companies fully exited Worldpay, Inc. in Q3 2019, selling an estimated $300M.
- American Century Companies's ten largest holdings make up 18% of its $99.6B portfolio in Q3 2019.
- American Century Companies opened 144 new positions and closed 204 in Q3 2019.
- American Century Companies's portfolio value fell 0.83% quarter-over-quarter to $99.6B.
Based on American Century Companies's 13F filing for Q3 2019, filed 13 Nov 2019.